Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_assertion description "[To this end, experience with DNMT inhibitors in hematologic malignancies other than MDS is reviewed in an effort to better understand the therapeutic potential of these agents and to define areas of future exploration in these settings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_assertion evidence source_evidence_literature NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_assertion SIO_000772 16341239 NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_assertion wasDerivedFrom befree-20150227 NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_assertion wasGeneratedBy ECO_0000203 NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP978630.RApbolxr-eJrIj1S2nCX0VuiTHTyImgy3VvPHjJcWqOPw130_provenance.